SSO 2019 - 72nd Annual Cancer Symposium of Society of Surgical Oncology
Mar 27 - Mar 30, 2019 | San DiegoCAUS
LARVOL is not affiliated with 72nd Annual Cancer Symposium of Society of Surgical Oncology and all trademarks, logos, and brand names are property of their respective owners
Showing 8 abstracts linked to Trials
Prospective Evaluation of Morbidity and Quality of Life (QoL) in Multivisceral Resection (MVR) for Retroperitoneal Sarcoma (RPS)
DPD and hENT1 are Not Predictive in Patients with Resected Pancreatic Cancer Treated with Adjuvant S-1 or Gemcitabine Chemotherapy: Collaborative Study of the JASPAC 01 Trial
Interim Analysis of a Randomized, Open-Label Phase II Study of Talimogene Laherparepvec Neoadjuvant Treatment Plus Surgery versus Surgery for Resectable Stage IIIB-IVM1a Melanoma
Axillary Lymph Node Ultrasound Following Neoadjuvant Chemotherapy in Biopsy-Proven Node-Positive Breast Cancer: Results from the SN FNAC Study
A Randomized Neoadjuvant Trial of Sequential Versus Concurrent Anthracycline with Trastuzumab and Paclitaxel Plus Trastuzumab in HER2+ Breast Cancer
Predictors of Acute Surgical Complications Following Wide Local Excision and Sentinel Lymph Node Biopsy for Melanoma – Analysis from a Prospective Clinical Trial
High-risk for Developing Breast Cancer: Differences Between White and African American Women
A Phase I Trial of Concurrent Immunotherapy and Irreversible Electroporation in the Treatment of Locally Advanced Pancreatic Adenocarcinoma